MEN1 and multiple endocrine neoplasia type 1: It serves as a crucial transcriptional activator for MLL1 and MLL2, thereby exerting significant influence on histone methylation modification.[10]MEN1 syndrome is a autosomal dominant disorder characterized by multiple tumorigenesis in endocrine organs, caused by loss‐of‐function mutations of MEN1.